Connect Biopharma Holdings (CNTB) Total Non-Current Liabilities (2023 - 2025)
Historic Total Non-Current Liabilities for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $11.9 million.
- Connect Biopharma Holdings' Total Non-Current Liabilities changed N/A to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year change of. This contributed to the annual value of $8.5 million for FY2024, which is 135059.83% up from last year.
- According to the latest figures from Q3 2025, Connect Biopharma Holdings' Total Non-Current Liabilities is $11.9 million.
- In the past 5 years, Connect Biopharma Holdings' Total Non-Current Liabilities ranged from a high of $11.9 million in Q3 2025 and a low of $467000.0 during Q2 2024
- For the 3-year period, Connect Biopharma Holdings' Total Non-Current Liabilities averaged around $6.0 million, with its median value being $8.5 million (2024).
- In the last 5 years, Connect Biopharma Holdings' Total Non-Current Liabilities tumbled by 371.13% in 2024 and then soared by 231134.9% in 2025.
- Over the past 3 years, Connect Biopharma Holdings' Total Non-Current Liabilities (Quarter) stood at $585000.0 in 2023, then surged by 1350.6% to $8.5 million in 2024, then soared by 39.9% to $11.9 million in 2025.
- Its last three reported values are $11.9 million in Q3 2025, $11.3 million for Q2 2025, and $9.2 million during Q1 2025.